Last reviewed · How we verify
Topical Adapalene, Benzoyl Peroxide Gel
At a glance
| Generic name | Topical Adapalene, Benzoyl Peroxide Gel |
|---|---|
| Sponsor | Treatment and Diagnostic Center of Private Enterprise "Asklepiy" |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Dry Skin
- Application Site Burning
- Nasopharyngitis
- Erythema
- Dry skin
- Headache
- Upper Respiratory Tract Infection
- Skin Desquamation
- Sunburn
- Influenza
- Application Site Irritation
- Dermatitis Contact
Key clinical trials
- Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study (PHASE2)
- Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel) (NA)
- Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris
- Auricular Acupressure Combined With Adapalene for the Treatment of Acne Vulgaris (NA)
- Experience With Topical Acne Treatment (EARLY_PHASE1)
- A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris. (PHASE1)
- Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris (PHASE3)
- MC RCT - BPO vs Adapalene (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: